| Axol Bioscience Ltd.. (6/7/23). "Press Release: Axol Bioscience Collaborates with StrataStem to Deliver Stem Cell Based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease". Cambridge, Edinburgh & Alderley Park. |
2023-06-07 |
| Digital Science. (6/7/23). "Press Release: Digital Science Boosts Pharma Industry Support Following OntoChem Acquisition". London & Halle (Saale). |
2023-06-07 |
| CN Bio Innovations Ltd.. (6/6/23). "Pressemitteilung: CN Bio Appoints Dr. Samantha Macro as Chief Financial Officer". Cambridge. |
2023-06-06 |
| Abzena Ltd.. (6/6/23). "Press Release: Abzena Appoints Thomas Castellano as Chief Financial Officer". San Diego, CA. |
2023-06-06 |
| Refeyn Ltd.. (5/31/23). "Press Release: Refeyn Announces Vice President of Sales and Marketing". |
2023-05-31 |
| eXmoor Pharma Concepts Ltd.. (5/30/23). "Press Release: eXmoor Pharma Completes $35 Million Series A to Expand Cell and Gene Therapy Manufacturing Capabilities". Bristol. |
2023-05-30 |
| BenevolentAI. (5/25/23). "Press Release: BenevolentAI Unveils Strategic Plan to Position the Company for a New Era in AI". London. |
2023-05-25 |
| Closed Loop Medicine Ltd.. (5/17/23). "Press Release: Closed Loop Medicine and Pharmanovia Enter a Co-development Partnership for Precision Medicine Combination Therapeutics". London & Basildon. |
2023-05-17 |
| H.E.L. Group. (5/16/23). "Press Release: H.E.L Group Makes Senior Appointments as It Continues to Scale Globally". London. |
2023-05-16 |
| Evonetix Ltd.. (5/15/23). "Press Release: Evonetix Delivers First Chip-synthesized DNA to the University of Cambridge". |
2023-05-15 |
| Bicycle Therapeutics plc. (5/10/23). "Press Release: Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology". Berlin, Cambridge & Boston, MA. |
2023-05-10 |
| Ascend Gene and Cell Therapies Ltd.. (5/9/23). "Press Release: Gene and Cell Therapy Manufacturing Specialist Ascend Launches with over $130M of Funding as Expert Teams Merge". London. |
2023-05-09 |
| Bicycle Therapeutics plc. (5/4/23). "Press Release: Bicycle Therapeutics Announces Collaboration With the German Cancer Research Center, to Discover and Develop Wholly Owned Bicycle® Radio Conjugates for a Range of Oncology Targets". Cambridge & Boston, |
2023-05-04 |
| OrbiMed Advisors LLC. (5/3/23). "Press Release: OrbiMed Expands to Europe, Opens London Office". New York, NY. |
2023-05-03 |
| MicrofluidX Ltd.. (5/2/23). "Press Release: MicrofluidX and Immatics Working Together on Automated End-to-End Bioprocessing for TCR-T Therapies". Stevenage & Houston, TX. |
2023-05-02 |
| LifeArc. (5/2/23). "Press Release: Dr Jason Slingsby Joins LifeArc as Chief Business Officer". |
2023-05-02 |
| Crescendo Biologics Ltd.. (4/27/23). "Press Release: Crescendo Biologics Appoints Angus Hone as Chief Financial Officer". Cambridge. |
2023-04-27 |
| GSK plc. (4/18/23). "Press Release: GSK Reaches Agreement to Acquire Late-stage Biopharmaceutical Company Bellus Health [For media and investors only]". London. |
2023-04-18 |
| Zetta Genomics Ltd.. (4/18/23). "Press Release: Zetta Genomics Secures £1.9 Million in Second Round Seed Funding to Configure for Scale, Delivery and Innovation". |
2023-04-18 |
| Refeyn Ltd.. (4/11/23). "Press Release: Refeyn Closes Series B Funding Round". Oxford. |
2023-04-11 |
| Vitarka Therapeutics Ltd.. (4/6/23). "Press Release: UK Biotech Start-up Secures £1.27M to Revolutionise Intracellular Drug Delivery through Tumour Targeted Technology". |
2023-04-06 |
| Syncona Ltd.. (4/5/23). "Press Release: Syncona Appoints Roel Bulthuis as Managing Partner". |
2023-04-05 |
| Mosaic Therapeutics Ltd.. (4/4/23). "Press Release: Mosaic Therapeutics Closes $28m Series A Funding and Appoints Brian Gladsden as CEO". Cambridge. |
2023-04-04 |
| Sofinnova Partners. (3/28/23). "Press Release: BioCorteX Raises $5 Million in Funding Led by Sofinnova Partners and Hoxton Ventures to Unlock Drug-bacteria Interactions". London. |
2023-03-28 |
| Bicycle Therapeutics plc. (3/28/23). "Press Release: Bicycle Therapeutics Announces a Strategic Collaboration with Novartis to Discover, Develop and Commercialize Bicycle® Radio-Conjugates". Cambridge & Boston, MA. |
2023-03-28 |
| Macomics Ltd.. (3/23/23). "Press Release: Macomics and Ono Pharmaceutical Partner to Discover and Develop Macrophage-targeting Antibody Therapy". |
2023-03-23 |
| Owlstone Medical Ltd.. (3/15/23). "Press Release: Owlstone Medical Enters Partnership with Bicycle Therapeutics for the Development of Antigen-Targeted EVOC Probes for Early Cancer Detection". Cambridge. |
2023-03-15 |
| CN Bio Innovations Ltd.. (3/14/23). "Press Release: CN Bio Appoints Deepak Singh as Vice President of Sales and Marketing". Cambridge. |
2023-03-14 |
| Exscientia plc. (3/14/23). "Press Release: Exscientia Announces Expansion of its Precision Oncology Pipeline". Oxford. |
2023-03-14 |
| Intellegens Ltd.. (3/9/23). "Press Release: Intellegens Celebrates Milestone Opening of New Cambridge Headquarters". Cambridge. |
2023-03-09 |
| Exscientia plc. (3/7/23). "Press Release: Exscientia Announces Collaboration with Charité to Advance Development of Precision Medicine Platform". Oxford & Berlin. |
2023-03-07 |
| Adaptimmune Therapeutics plc. (3/6/23). "Press Release: Adaptimmune and TCR2 Therapeutics Announce Strategic Combination to Create a Preeminent Cell Therapy Company for Solid Tumors". Philadeliphia, PA, Oxford & Canbridge, MA. |
2023-03-06 |
| Antiverse Ltd.. (3/1/23). "Press Release: Antiverse Raises Funding and Demonstrates Therapeutic Antibody Identification with AI-driven Drug Discovery platform". Cardiff. |
2023-03-01 |
| Bicycle Therapeutics plc. (2/28/23). "Press Release: Bicycle Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update". Cambridge & Boston, MA. |
2023-02-28 |
| Five Alarm Bio Ltd.. (2/27/23). "Press Release: Five Alarm Bio, Focused on Minimising the Effects of Aging in Humans, Raises Seed Investment". Cambridge. |
2023-02-27 |
| eXmoor Pharma Concepts Ltd.. (2/22/23). "Press Release: eXmoor Pharma and Vaccine Developer Imophoron Sign Process Development Partnership". Bristol. |
2023-02-22 |
| Consilium Strategic Communications Ltd.. (2/20/23). "Press Release: Consilium Strategic Communications Expands International Presence in US and Europe with Two Senior Strategic Advisor Appointments". London. |
2023-02-20 |
| Lift BioSciences Ltd.. (2/16/23). "Press Release: LIfT BioSciences and Minaris Regenerative Medicine Enter into a Manufacturing Partnership". London & Munich. |
2023-02-16 |
| Maxion Therapeutics Ltd.. (2/15/23). "Press Release: Maxion Therapeutics’ $16 Million Series A to Drive Antibody Development for Previously Untreatable Ion Channel and GPCR-driven Diseases". Cambridge. |
2023-02-15 |
| Refeyn Ltd.. (2/14/23). "Press Release: Refeyn Launches SamuxMP Auto for Automated AAV Capsid Analysis". Oxford. |
2023-02-14 |
| Bicycle Therapeutics plc. (2/14/23). "Press Release: Bicycle Therapeutics Announces Phase I Dose Escalation Results from Ongoing Phase I/II Study of BT8009". Cambridge & Boston, MA. |
2023-02-14 |
| Cydar Ltd.. (2/13/23). "Press Release: Cydar Medical Raises $11.5M (£9.3M) in Series A Funding Round". Cambridge. |
2023-02-13 |
| Freeline Therapeutics Holdings plc. (2/10/23). "Press Release: Freeline Announces Closing of Sale of Its CMC-focused German Subsidiary". London. |
2023-02-10 |
| Evonetix Ltd.. (2/7/23). "Press Release: Evonetix Closes $24 Million USD (£20 Million) Financing. Oversubscribed Round Led by Foresite Capital". Cambridge. |
2023-02-07 |
| Oxford Science Enterprises plc. (2/7/23). "Press Release: Oxford Science Enterprises Strengthens Life Sciences Investment Team with Appointment of Sanne de Jongh as Partner". Oxford. |
2023-02-07 |
| BioIndustry Assocation (BIA). (1/25/23). "Press Release: BIA Announces New Appointments to the BIA Board". |
2023-01-25 |
| Refeyn Ltd.. (1/23/23). "Press Release: Refeyn Appoints Interim CEO". |
2023-01-23 |
| Optibrium Ltd.. (1/17/23). "Press Release: Optibrium Appoints Steve Yemm as Chief Commercial Officer". Cambridge. |
2023-01-17 |
| Green Bioactives Ltd.. (1/17/23). "Press Release: Green Bioactives Appoints Experienced Biotech Leaders Chris Meaney and Andy Hall-Ponselé to Expand Senior Management Team". Edinburgh. |
2023-01-17 |
| AstraZeneca plc. (1/16/23). "Press Release: Acquisition of Neogene Therapeutics Completed". |
2023-01-16 |
| AstraZeneca plc. (1/9/23). "Press Release: AstraZeneca to Acquire CinCor Pharma to Strengthen Cardiorenal Pipeline". |
2023-01-09 |
| Astrea Bioseparations. (1/9/23). "Press Release: Astrea Bioseparations Acquires Delta Precision Ltd, a Leading Manufacturer of Chromatography Columns for Biomanufacturing". |
2023-01-09 |
| BioNTech SE. (1/6/23). "Press Release: BioNTech Announces Strategic Partnership with UK Government to Provide up to 10,000 Patients with Personalized mRNA Cancer Immunotherapies by 2030". Mainz. |
2023-01-06 |
| Akamis Bio Ltd.. (1/5/23). "Press Release: Akamis Bio Announces $30 Million Financing, Provides Clinical Program Update and Relaunches with Name Change from PsiOxus Therapeutics". Cambridge, MA & Oxford. |
2023-01-05 |
| Bicycle Therapeutics plc. (1/4/23). "Press Release: Bicycle Therapeutics Announces FDA Fast Track Designation Granted to BT8009 for the Treatment of Adult Patients with Previously Treated Locally Advanced or Metastatic Urothelial Cancer". Cambridge & Bos |
2023-01-04 |
| Actimed Therapeutics Ltd.. (1/4/23). "Press Release: Actimed Therapeutics Successfully Closes Second Tranche of £10m Seed Financing". London. |
2023-01-04 |
| Stablepharma Ltd.. (12/23/22). "Press Release: Stablepharma Closed Series A Funding round of $6.4m to Progress Fridge-free Vaccines and mRNA/LNP Stabilisation Technologies". |
2022-12-23 |
| Oxford Biomedica plc. (12/22/22). "Press Release: Oxford Biomedica to Present at 41st Annual J.P. Morgan Healthcare Conference". Seattle, WA. |
2022-12-22 |
| Lift BioSciences Ltd.. (12/19/22). "Press Release: Lift BioSciences Investors Increase Investment in Lift and Johnson and Johnson Welcomes Lift into JLABS". London. |
2022-12-19 |
| CN Bio Innovations Ltd.. (12/19/22). "Press Release: CN Bio Appoints Dr Paul Brooks as Chief Executive Officer". Cambridge. |
2022-12-19 |
| Ori Biotech Ltd.. (12/15/22). "Press Release: Ori Biotech and Inceptor Bio Partner to Accelerate Solid Tumor Cell Therapy Access". London & Morrisville, NC. |
2022-12-15 |
| Storm Therapeutics Ltd.. (12/14/22). "Press Release: Storm Therapeutics Announces Closing of USD $30M Series B Financing". Cambridge. |
2022-12-14 |
| PrecisionLife Ltd.. (12/14/22). "Press Release: PrecisionLife Enters into a Multi Target R&D Collaboration Agreement with Ono Pharmaceutical". Oxford. |
2022-12-14 |
| PhoreMost Ltd.. (12/14/22). "Press Release: PhoreMost and ThinkCyte Collaborate to Advance AI Based Drug Discovery". Cambridge. |
2022-12-14 |
| Oxford Biomedica plc. (12/14/22). "Press Release: Oxford Biomedica Solutions Forms New Partnerships with Three Biotechnology Companies". Oxford. |
2022-12-14 |
| Green Bioactives Ltd.. (12/13/22). "Press Release: Green Bioactives Completes £2.6m Seed Financing to Advance Its Sustainable Plant Products Biomanufacturing Platform". Edinburgh. |
2022-12-13 |
| MicrofluidX Ltd.. (12/8/22). "Press Release: MicrofluidX Raises £3.3 Million to Develop Their Next Generation Advanced Therapy Manufacturing Platform". Stevenage. |
2022-12-08 |
| Coulter Partners. (12/6/22). "Press Release: Coulter Partners Appoints Dr. Hannah Musisi as Executive Director". |
2022-12-06 |
| AstraZeneca plc. (11/29/22). "Press Release: AstraZeneca to Acquire Neogene Therapeutics, Accelerating Ambition in Oncology Cell Therapy". |
2022-11-29 |
| Touchlight Genetics Ltd.. (11/29/22). "Press Release: Touchlight Receives Grant to Advance Rapid, Scalable and Thermostable doggybone DNA Vaccine Platform". Hampton. |
2022-11-29 |
| V7 Ltd.. (11/28/22). "Press Release: V7 Raises a $33m Series A to Help Teams Build Robust AI, Faster". London. |
2022-11-28 |
| Oxford Biomedica plc. (11/22/22). "Press Release: Oxford Biomedica Appoints Dr Frank Mathias as Chief Executive Officer". Oxford. |
2022-11-22 |
| Turbine Simulated Cell Technologies Ltd.. (11/22/22). "Press Release: Turbine Raises €20 Million in Series A Financing to Advance Programs & Partnerships Towards the Clinic with World’s First Cancer Cell Simulation Platform". London & Budapest. |
2022-11-22 |
| Accession Therapeutics Ltd.. (11/21/22). "Press Release: Accession Therapeutics Raises £16.6m to Advance Potent Immunotherapies towards Clinical Trials". Oxford. |
2022-11-21 |
| Touchlight Genetics Ltd.. (11/15/22). "Press Release: Touchlight Signs License Agreement with Voyager for Use of Touchlight’s DNA Technology in Voyager’s Capsid Discovery Platform". Hampton. |
2022-11-15 |
| NRG Therapeutics Ltd.. (11/9/22). "Press Release: NRG Therapeutics Announces £16 Million Series A to Advance Mitochondrial Therapeutics for Parkinson’s and ALS". Stevenage. |
2022-11-09 |
| Adaptimmune Therapeutics plc. (11/8/22). "Press Release: Adaptimmune Reports Third-Quarter Financial Results and Business Update". Philadelphia, PA & Oxford. |
2022-11-08 |
| PrecisionLife Ltd.. (11/8/22). "Press Release: PrecisionLife to Evaluate Precision Medicine Potential of Sosei Heptares Neuroscience GPCR Target". |
2022-11-08 |
| Ubiquigent Ltd.. (11/7/22). "Press Release: Ubiquigent Appoints Dr Hozefa Amijee as Head of Business Development". Dundee. |
2022-11-07 |
| Bruker Corporation. (11/7/22). "Press Release: Bruker Corporation to Participate in the 2022 Jefferies London Healthcare Conference". Billerica, MA. |
2022-11-07 |
| OxSonics Therapeutics Ltd.. (11/7/22). "Press Release: Jérôme Marzinski Appointed as Chief Executive Officer". Oxford. |
2022-11-07 |
| Exscientia plc. (11/3/22). "Press Release: Exscientia Expands Biologics Design Capability with Automated Laboratory". Oxford. |
2022-11-03 |
| Affimed N.V.. (11/1/22). "Press Release: Affimed to Present at the 2022 Jefferies London Healthcare Conference". Heidelberg. |
2022-11-01 |
| Exscientia plc. (11/1/22). "Press Release: Exscientia to Present at Upcoming Investor Conferences in November". Oxford. |
2022-11-01 |
| Eagle Genomics Ltd.. (10/31/22). "Press Release: Eagle Genomics Announces USD 20M First Close, Scale-up Funding to Accelerate the Application of Microbiome Science for Global ‘One Health’ Innovation". Cambridge. |
2022-10-31 |
| PhoreMost Ltd.. (10/28/22). "Press Release: PhoreMost Enters Multi-target Collaboration with Targeted Protein Degradation Leader Arvinas". Cambridge. |
2022-10-28 |
| Medicines Discovery Catapult (MDC). (10/26/22). "Press Release: Medicines Discovery Catapult Appoints International Entrepreneur Volker Hirsch to Bolster Commercial Expertise". |
2022-10-26 |
| Adaptimmune Therapeutics plc. (10/25/22). "Press Release: Adaptimmune Enhances Its Pipeline of Wholly Owned Cell Therapies for Cancer with Transfer of PRAME and NY-ESO Target Programs from GSK". Philadelphia, PA & Oxford. |
2022-10-25 |
| Green Bioactives Ltd.. (10/24/22). "Press Release: Green Bioactives Appoints David McElroy as CEO ". Edinburgh. |
2022-10-24 |
| Enhanc3D Genomics Ltd.. (10/20/22). "Press Release: Enhanc3D Genomics Raises £10 Million in Series A Financing to Advance GenLink3D Proprietary Technology Platform". Cambridge. |
2022-10-20 |
| Nucleome Therapeutics Ltd.. (10/19/22). "Press Release: Nucleome Therapeutics Raises oversubscribed £37.5 Million Series A Financing to Decode the Dark Matter of the Human Genome and Deliver First-in-Class Precision Medicines". Oxford. |
2022-10-19 |
| GSK plc. (10/18/22). "Press Release: GSK Announces Expanded Collaboration with Tempus in Precision Medicine to Accelerate R&D". London. |
2022-10-18 |
| PBD Biotech Ltd.. (10/17/22). "Press Release: PBD Biotech Raises further £2.4m for Its Breakthrough Tuberculosis Blood Test". |
2022-10-17 |
| Innovation Zero. (10/17/22). "Press Release: Major Climate and Cleantech Congress Announces First International Trade and Innovation Keynote Speakers". London. |
2022-10-17 |
| Coulter Partners. (10/6/22). "Press Release: Coulter Partners and Differing Minds Announce Partnership Agreement". |
2022-10-06 |
| Cytiva. (10/6/22). "Press Release: Cytiva Strengthens Cell Line Development with Cevec Acquisition". |
2022-10-06 |
| Pheon Therapeutics Ltd.. (9/28/22). "Press Release: Pheon Therapeutics Launches with $68 Million in Financing to Advance Novel Antibody-Drug Conjugates for Treatment of Solid Tumors". London. |
2022-09-28 |
| GSK plc. (9/22/22). "Press Release: GSK and Spero Therapeutics Announce Exclusive Licence Agreement for tebipenem HBr, a Late-stage Antibiotic that May Treat Complicated Urinary Tract Infections". London. |
2022-09-22 |
| Beckman Coulter Life Sciences. (9/13/22). "Press Release: ValitaCell Joins Beckman Coulter Life Sciences". Indianapolis, IN & Dublin. |
2022-09-13 |
| Ori Biotech Ltd.. (9/13/22). "Press Release: Ori Biotech and CTMC Partner to Accelerate Novel Cell Therapy Delivery". London & Houston, TX. |
2022-09-13 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
